KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax RateWages, Salaries and Other
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares RepurchasedWages, Salaries and Other
Ratios

Encompass Health (EHC) Shares Outstanding (2016 - 2026)

Encompass Health (EHC) has disclosed Shares Outstanding for 18 consecutive years, with $99.4 million as the latest value for Q1 2026.

  • For Q1 2026, Shares Outstanding fell 1.49% year-over-year to $99.4 million; the TTM value through Mar 2026 reached $99.4 million, down 1.49%, while the annual FY2025 figure was $100.0 million, 0.79% down from the prior year.
  • Shares Outstanding hit $99.4 million in Q1 2026 for Encompass Health, down from $100.0 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $100.9 million in Q1 2025 and bottomed at $99.4 million in Q1 2026.
  • Average Shares Outstanding over 5 years is $100.3 million, with a median of $100.2 million recorded in 2023.
  • Year-over-year, Shares Outstanding increased 0.6% in 2024 and then fell 1.49% in 2026.
  • Encompass Health's Shares Outstanding stood at $99.8 million in 2022, then grew by 0.5% to $100.3 million in 2023, then increased by 0.5% to $100.8 million in 2024, then decreased by 0.79% to $100.0 million in 2025, then dropped by 0.6% to $99.4 million in 2026.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $99.4 million, $100.0 million, and $100.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.